Publications

Inflammatory Bowel Disease
C. difficile Infection
Gram-negative Infections

Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection

Correspondence to “Escape Velocity—the Launch of Microbiome Therapies”

Commensal consortia decolonize Enterobacteriaceae via ecological control

Opportunities and Challenges in Development of Live Biotherapeutic Products To Fight Infections

VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial

Colonization of the live biotherapeutic product VE303 and modulation of the microbiota and metabolites in healthy volunteers

A gut punch fights cancer and infection

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity

Computer-guided design of optimal microbial consortia for immune system modulation

Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease

Pages: 12